The Blogs: Dec 15, 2011

Time to Share Your Biomanufacturing Opinions

Eric Langer

It’s time you shared your valuable opinions: Yes--doing surveys is a pain.  So there’d better be a darn good reason.  Here’s one with 7 good reasons where both the industry and participants benefit: the 9th Annual Report and Survey of Biopharmaceutical Manufacturing. Here’s why:  

1)  Study questions are relevant, ‘real-world’; developed by a non-profit global panel of industry experts—The Biotechnology Industry Council™, a group of 270 biomanufacturers provide subject matter expertise, and submit, a set of the industry’s most urgent questions and issues.
2)  Few comprehensive, quantitative analyses of this industry exist—The Annual Report includes responses from 350 - 450 biomanufacturers annually. Plus 180-200 vendors also participate.
3)  Trends over time present a compelling story—Biopharma trends over 9 years describe changes over time, and correlate with real-world trends and experiences. A compelling picture of the industry’s strengths and future direction.
4)  Participants Get Trend Data First, and Free—Respondents get free summaries of current data, aggregated from participants in over 30 countries.  Data are accurate, and valid.
5)  Participants See the Most Urgent Issues—The study questions alone show what is most important to industry thought-leaders.
6)  Contributing to Industry Benchmarking—Perhaps most important, you’re contributing to benchmarking of current issues:
   a.    Budget trends
   b.    New technologies developed by suppliers
   c.    New technologies demanded by end-users
   d.    Hiring trends
   e.    Outsourcing & offshoring effect on current jobs
   f.    Productivity and layoffs
  g.    Impact of biosimilars
  h.    Capacity bottlenecks from downstream production
  i.    Quality management processes
  j.    New technology adoption rates, for bioreactors, single-use systems, alternatives to Protein-A, and many others
7)  Contributing to Global Health—Participants not only receive a summary of the study, but also a $10 donation on their behalf to global health charities—up to $10,000.

Paste the link below to a browser: TO PARTICIPATE &  FOR YOUR FREE SUMMARY
http://www.surveymonkey.com/s/BLOG-GEN

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Potential of Synthetic Biology

Do you think synthetic biology has the ability to offer solutions for problems related to health and the environment?

Suggest a Poll